NERV   $2.175  -2.90% Market Closed

Minerva Neurosciences Inc
Total Cash 30.88M
totalCashPerShare 4.416
EBITDA -26.21M
Total Debt 86.58M
quickRatio 7.347
currentRatio 7.472
Total Revenue
debtToEquity
Revenue/Share
ROA -0.28884
ROE
grossProfits
freeCashflow -17.93M
operatingCashflow -20.83M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 72.45M
forwardPE -1.1621675
floatShares 5.44M
sharesOutstanding 6.99M
sharesShort 7.21K
sharesShortPriorMonth 7.71K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.22%
heldPercentInstitutions 0.30%
Short Ratio help_outline 0.63%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -6.362
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -33.65M
trailingEps -4.40%
forwardEps -2.03%
enterpriseToEbitda -2.77
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.01 3Q 2024
institutionsCount 24
lastUpdated Nov. 1, 2024, 10:11 p.m.